Press release
Trends in the Dysmenorrhea Treatment Market 2016 - 2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause pain and decrease blood flow and oxygen to the uterus. A wide variety of underlying condition can contribute to menstrual disorders. To pinpoint the cause, physician generally rely on the patient’s medical history, physical examination, and laboratory test. This determines the exact cause of menstrual disorder and helps the physician to plan appropriate treatment. This has grabbed the attention of dysmenorrhea drug manufacturers to develop and commercialize more effective medicines to treat dysmenorrhea.Dysmenorrhea Treatment Market: Drivers and Restraints
Increasing incidence of dysmenorrhea, high awareness level and growing concern about dysmenorrhea among females from developed countries, involvement of companies for developing innovative drugs, and government campaigns with respect to women healthcare are effectively endorsing the growth of dysmenorrhea treatment market. However, side effect and complications of long term treatment, substantial morbidity of dysmenorrhea which leads to inadequate treatment, and traditional values of families would hinder the growth of dysmenorrhea treatment market.
Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1312
Dysmenorrhea Treatment Market: Segmentation
The global dysmenorrhea treatment market is segmented based type of disease, and therapeutic class.
Based type of diseases, the global dysmenorrhea market is segmented into the following:
Primary dysmenorrhea
Secondary dysmenorrhea
Endometriosis
Adenomyosis
Uterine myomas
Endometrial polyps
Cervical stenosis
Obstructive malformations of genital tract
Based on therapeutic class, the global dysmenorrhea treatment market is segmented into the following:
Non-hormonal medical treatment
Non-steroidal anti-inflammatory drugs (NSAIDs)
Non-selective NSAIDs
COX-2 inhibitors
Transdermal glyceryl trinitrate
Over-the-counter (OTC) medications
Hormonal medicine treatment
Combined oral contraceptive
Progestin regimens
Levonorgestrel intrauterine system (LN-IUS)
Surgical options
Laparoscopy
Hysterectomy
Presacral neurectomy
Laparoscopic uterosacral nerve ablation (LUNA)
Intrauterine device (IUD)
Dysmenorrhea Treatment Market: Overview
By non-hormonal medical treatment, NSAID’s such as Ibuprofen and Naproxen, are most commonly used drugs for the treatment of dysmenorrhea and hold prominent share owing to its lower cost and easy availability. COX-2 inhibitors have also proven effective in relieving pain, and would gain prominence in developed countries. Physicians also prescribe hormonal medicine treatment such as contraceptive pills to regularize the menstrual bleeding will gain good market share in emerging countries.
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1312
Dysmenorrhea Treatment Market: Region-wise Outlook
Geographically, the North America accounts for the largest market share followed by Europe, in terms revenues and research activities. In addition. APEI market is also expected to grow significantly in the coming years owing to support of government and non-profit organizations in awareness campaigns, growing number of patients suffering with dysmenorrhea, and high disposable income.
Dysmenorrhea Treatment Market: Key Players
Key companies operational in dysmenorrhea treatment market are Novartis Pharmaceuticals Corporation, Merck, Inc., Bayer Schering Pharma AG, Vanita Therapeutics, Alvogen, Pfizer, Inc., Roche Laboratories, Taj Pharmaceuticals, Ltd., Sanofi, Terramedic, Inc., and others.
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Trends in the Dysmenorrhea Treatment Market 2016 - 2026 here
News-ID: 655966 • Views: …
More Releases from Future Market Insights

Crane Rental Market: Anticipated Growth to Reach USD 95.8 Billion by 2033
The Cranes Rental Market report, unveiled by Future Market Insights-an ESOMAR Certified Market Research and Consulting Firm-presents invaluable insights and meticulous analysis of the Cranes Rental market. This comprehensive report thoroughly examines the driving factors, market size, and predictive data for the Cranes Rental sector. It provides detailed revenue and shipment segmentations, accompanied by a ten-year projection extending up to 2033. Additionally, the document evaluates key industry players, their market…

Global Compressor Rental Market Growth: Industry Projected USD 8.7 billion by 20 …
The global compressor rental market is poised for substantial growth, with its value projected to surge from USD 4.2 billion in 2023 to an impressive USD 8.7 billion by 2033. This robust expansion is anticipated to be driven by a remarkable 7.5% compound annual growth rate (CAGR) during the forecast period spanning 2023 to 2033.
In 2022, the compressor rental industry witnessed a significant valuation of USD 3.9 billion, setting the…

Terminal Management System Market Size is to Reach USD 1,390.0 Million by 2033, …
The terminal management system Market report, unveiled by Future Market Insights-an ESOMAR Certified Market Research and Consulting Firm-presents invaluable insights and meticulous analysis of the terminal management system market. Encompassing the research's scope and essence, this report scrupulously examines the driving factors, market size, and predictive data for terminal management system. It furnishes intricate revenue and shipment segmentations, accompanied by a decade-long projection up to 2033. Additionally, the document evaluates…

Intelligent Packaging Market Analysis: Opportunities, Challenges, and Regional T …
The intelligent packaging market is rapidly expanding, driven by advancements in smart sensors, IoT integration, and sustainability trends. Intelligent packaging enhances product safety, traceability, and shelf life, making it crucial for food, pharmaceuticals, and logistics industries. Technologies such as RFID, NFC, temperature indicators, and QR codes enable real-time monitoring and authentication.
Growing concerns over food waste, counterfeiting, and regulatory compliance are fueling adoption. North America and Europe lead in technological innovation,…
More Releases for Dysmenorrhea
Dysmenorrhea Treatment Market: Market Intelligence and Market Trends
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Trends in the Dysmenorrhea Treatment Market 2016 - 2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Market Intelligence Research Reports for Actionable Insig …
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Market Insights and Analysis for Period 2016-2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Market size and forecast, 2016-2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Survey and 2027 Foresight Report
Dysmenorrhea Treatment: Market Overview
Globally, more than 50% of post pubescent menstruating women are affected by dysmenorrhea, with 10–12% of them having severe dysmenorrhea with incapacitation for 1–3 days each month. Because young women constitute a significant percentage of the adult work force in the US, nearby 600 million working hours or 2 billion dollars are lost annually because of incapacitating dysmenorrhea if adequate relief is not provided. Women who continue…